StoneX Group’s GSK GSK Stock Holding History

StoneX Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$214K	Buy	+4,051	New	+$214K	0.01%	1060
2024 Q1	–	Sell	-7,197	Closed	-$267K	–	675
2023 Q4	$267K	Buy	+7,197	New	+$258K	0.03%	442
2023 Q3	–	Sell	-6,251	Closed	-$224K	–	682
2023 Q2	$224K	Buy	+6,251	New	+$224K	0.02%	500
2022 Q1	–	Sell	-4,578	Closed	-$255K	–	650
2021 Q4	$255K	Buy	+4,578	New	+$238K	0.03%	452
2017 Q3	–	Sell	-30,446	Closed	-$1.64M	–	244
2017 Q2	$1.64M	Buy	30,446 +18,328	+151%	+$977K	0.51%	51
2017 Q1	$583K	Sell	12,118 -156	-1%	-$7.91K	1.3%	37
2016 Q4	$591K	Sell	12,274 -3,080	-20%	-$152K	1.03%	48
2016 Q3	$828K	Buy	+15,354	New	+$842K	1.85%	16

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

StoneX Group's GSK Position: Q2 2026 in Review

StoneX Group opened a new position in GSK (GSK) in Q2 2026: 4,051 shares worth $214K. The stake represents 0.01% of the portfolio and ranks #1060 among its holdings. This is a return to the name: StoneX Group previously reported a position in GSK as recently as Q4 2023.

StoneX Group first reported a position in GSK in Q3 2016 and has held it in 8 quarters since. The position peaked at $1.64M in Q2 2017. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

StoneX Group held 4,051 shares of GSK worth $214K as of Q2 2026.
GSK was a new StoneX Group position in Q2 2026.
GSK made up 0.01% of StoneX Group's portfolio in Q2 2026, its #1060 holding.
StoneX Group first reported a position in GSK in Q3 2016 and has held it in 8 quarters since.
StoneX Group's GSK position peaked at $1.64M in Q2 2017.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.